Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Influencer and podcast maven Claudia Oshry used Ozempic to kickstart a newfound wellness journey.
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...
WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...
Sure, who wouldn’t want to lose a few pounds? But what’s really driving Hollywood’s latest trend is the drug’s seemingly miraculous side benefits ...
Kristina Schmidt, 24, developed agonizing pain in her right hip that “felt like someone was tearing her leg off” and ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...
While GLP-1 therapies like Ozempic gain traction, personalized peptide therapies are supporting long-term health goals outside the mainstream.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results